Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

2.73
+0.01000.37%
Post-market: 2.780.0500+1.83%16:49 EDT
Volume:46.73K
Turnover:129.18K
Market Cap:87.89M
PE:-6.94
High:2.80
Open:2.79
Low:2.72
Close:2.72
Loading ...

BRIEF-Anixa Biosciences- Receives Notice Of Allowance For Car-T Technology Patent

Reuters
·
14 Apr

Anixa Biosciences Inc - Receives Notice of Allowance for CAR-T Technology Patent

THOMSON REUTERS
·
14 Apr

Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine

MT Newswires Live
·
10 Apr

BRIEF-Anixa Biosciences Receives Notice Of Allowance From U.S. Patent And Trademark Office

Reuters
·
09 Apr

Anixa Biosciences Receives Notice of Allowance From U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

THOMSON REUTERS
·
09 Apr

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

PR Newswire
·
09 Apr

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

Benzinga
·
09 Apr

Anixa Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
26 Mar

Anixa Enters Letter of Intent to Develop Verdi's AI-Guided Cancer Vaccines

MT Newswires Live
·
25 Mar

BRIEF-Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Reuters
·
25 Mar

Anixa Biosciences Enters Letter of Intent With Verdi Solutions to Develop Artificial Intelligence-Guided Personalized and off-the-Shelf Cancer Vaccines

THOMSON REUTERS
·
25 Mar

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines

Benzinga
·
25 Mar

Anixa Biosciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Mar

Anixa Biosciences: Buy Rating Affirmed Amid Patent Approval and Clinical Trial Advancements

TIPRANKS
·
25 Mar

Anixa Biosciences Receives US Patent Notice of Allowance for Potential Ovarian Cancer Vaccine

MT Newswires Live
·
24 Mar

BRIEF-Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Reuters
·
24 Mar

Anixa Biosciences Receives Notice of Allowance From Uspto for Ovarian Cancer Vaccine

THOMSON REUTERS
·
24 Mar

Anixa Biosciences Holds Annual Stockholder Meeting 2025

TIPRANKS
·
22 Mar

Anixa Biosciences Initiated at Buy by Maxim Group

Dow Jones
·
21 Mar

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

PR Newswire
·
17 Mar